11-03-2008: The 2008 European Immunoassay Frost & Sullivan Excellence in Technology Award has been awarded to Chimera Biotec. Chimera Biotec is recognized for its pioneering Imperacer® ultra-sensitive immunoassay system, which has a 1000-fold better sensitivity compared to ELISA (Enzyme-linked Immunosorbent Assay), according to the company. With a unique value proposition in the drug development and diagnostic markets, Chimera's innovative Imperacer® products and services have experience widespread market acceptance.
“Imperacer® has a proven record for quantifying low-abundant proteins, peptides, biomarkers and a range of “difficult to quantify” markers”, says Mark Spengler, Product Manager at Chimera Biotec. “Among others Imperacer® is currently being used in fields like Alzheimer’s, rheumatoid arthritis, cardiovascular and cancer.”
Launched in 2005, Imperacer® has been successfully used in a number of applications like drug development (preclinic & clinic), vaccine development, diagnostics, anti-doping testing, and proteomics. Imperacer® usually is 3 orders of magnitude more sensitive than any ELISA and is, therefore, mainly used for quantifying low abundant markers that cannot be quantified using conventional ELISA or electrochemiluminescence- technologies (ECL). Imperacer® is characterized by a broad linearity of up to 5 orders of magnitude and can be adapted to sample volumes of less than a microliter. Complementary to Imperacer®, Chimera developed a range of proprietary technologies for eliminating sample interferences (AnySource® technology) and analyte stabilization.
“After having been successfully introduced Imperacer® in research labs in 7 out of TOP 20 pharmaceutical and biotech companies in the U.S. and Switzerland we are now actively exploring broader global markets to expand our services," states Jan Detmers, CEO of Chimera Biotec.
Drug Development Technology: Frost & Sullivan Award goes to Imperacer
The 2008 European Immunoassay Frost & Sullivan Excellence in Technology Award has been awarded to Chimera Biotec. Chimera Biotec is recognized for its pioneering Imperacer® ultra-sensitive immunoassay system, which has a 1000-fold better sensitivity compared to ELISA (Enzyme-linked Immunoso ... more
CNS-Diagnostics: Chimera Biotec Starts Study on Novel Biomarker Detection for Alzheimer's Disease
Chimera Biotec joins the EU funded EDAR project to adapt the Imperacer(TM) platform technology for the detection of novel biomarkers for the diagnosis of Alzheimer's disease. The consortium wants to find out whether the new markers can be used to test efficacy of new drugs, thereby contribu ... more
1,000 times higher sensitivity for doping testing available now
Dr. Michael Adler, head of R&D at Chimera Biotec GmbH, Dortmund, Germany, and his group develop an ultra sensitive test for the detection of myostatin doping together with the team of Dr. Patrick Diel at the German Sports University, Cologne, Germany. The project, using Chimera IMPERACER pl ... more
For the understanding of interactions in the muscle-growth directing myostatin-pathway and therefore also for the establishment of high sensitive detection strategies for gene-doping, detailed studies of protein concentration levels in biological matrices and appropriate highly sensitive an ... more
Despite the negative impact of the 2008 economic recession, the global flow sensors and transmitters market is expected to grow. The rising number of projects, the establishment of new process plants, the financial recovery of numerous end-user industries, as well as reinvestment in plant r ... more
Over the years, the basic principle of sensor operation has remained unchanged and so has the working methodology of advanced sensors. What has changed, however, is the type of materials and sensing principles employed in the manufacture of new sensors. Sensing technologies are expected to ... more
Growth for Vacuum Pumps is in High-Tech Applications, According to Frost & Sullivan
The European vacuum pumps market is anticipated to witness growth, fuelled by high-tech applications for vacuum technologies and the rising awareness of the benefits of using vacuum systems.New analysis from Frost & Sullivan, Strategic Analysis of the European Vacuum Pumps Market, finds tha ... more
About analytica-world.com
analytica-world.com is the industry portal of the international trade fair analytica, which is organized by Messe München. It features useful information about markets, trends and innovations. It is operated by CHEMIE.DE, one of analytica's official sales partners.
Advertising at analytica-world.com
Our advertising formats support you in getting your message across to a clearly defined target audience.
The global network of analytica trade fairs:
